Integrating Network Pharmacology and In Vivo Model to Investigate the Mechanism of Biheimaer in the Treatment of Functional Dyspepsia

Figure 7

(a) The heat map of binding energy between the active compounds and IL-1β, CXCL8, NOS2, NOS3, TRPV1, and SLC6A4. (b) Molecular docking site of NOS3 and Isorupestonic acid.

(a)

(b)